Journal
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Volume 18, Issue 5, Pages 1051-1057Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10837450.2011.653822
Keywords
Polyamidoamine dendrimers; PAMAM; puerarin; puerarin-PAMAM complex; solubility; pharmacokinetics
Categories
Funding
- Major State Basic Research Development Program of the National Science and Technology of China [2010CB735602]
- Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutcial University
Ask authors/readers for more resources
The potential of polyamidoamine (PAMAM) dendrimers as solubility enhancers and oral drug delivery system was well known. Herein, we investigated the possibility of PAMAM dendrimers for promoting the solubility and oral bioavailability of puerarin. In the present study, the effect of PAMAM dendrimers with different generations (G1.5, G2, G2.5, and G3) on the solubility of puerarin was evaluated at different concentrations and pH conditions. Further more, the puerarin-G2 dendrimer complex was conducted for the in vitro hemolytic toxicity studies and pharmacokinetics studies in rats. The solubility of puerarin was significantly higher in the presence of the full generation dendrimers (e. g. G2 and G3). No significant hemolysis was observed on erythrocytes (G2, 0-2.5 mg/mL) in the hemolytic toxicity studies. The pharmacokinetics parameters T-max, C-max, and AUC(0-8 h) of puerarin suspension solution and puerarin-G2 dendrimer complex solution were 0.76 h, 1.50 mu g/mL, 7.33 mu g.h/mL and 0.33 h, 6.49 mu g/mL, 14.02 mu g.h/mL, respectively. These studies demonstrate that PAMAM dendrimers may be a promising strategy for peroral delivery of puerarin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available